Member Info for Schlum

Another three year contract announced. £900k over three years.

The company is gaining traction, it appears.

J P Morgan reiterates its bullish stance on AI. Suggests the market is booming , setting a rocket under Nvidia shares.

Looking positive for MFAI and its stable of AI companies.

Partnership with AZ is now advanced , with any successful conclusion likely to also generate double digit millions in licensing deals.

Company has a small mkt cap and now the cash to complete its research projects with major companies. Risk/reward is compelling.

As you have not bothered reading the RNSs, I suggest you do, especially the Final results.

As company have previously stated, conversations re the sale of part or all of GetVisibility have already taken place. No one really knows how these conversations are progressing.

Revenue continues to grow at pace. After cash and stock , the valuation of HUD is particularly undemanding for a fast growing £12m revenue business.

The mkt caps of many small U.K. biotech companies are such, that opportunistic takeover by US corporations may be the saddish? end to a lot of great research work.

Still moving higher. A decent RNS would be just the ticket.

Cash must be tight, Directors will be looking at all possibilities.

Well you got this one right. Salute.

The last time these islands were threatened with starvation and invasion, Harland and Wolff was one of the major yards that

Saved this country through building scores of merchant and naval ships.

Thanks to this Labour Government it may not be there to save us in the future.

If H and W is now sold for a knock down price to say Ba…..ck, then conspiracy theories will flare into life.

By refusing H and W but funding the construction of a new N.I.soccer/hurling stadium, maybe the Labour Party is showing its colours.

However there is no doubt that John Wood and his Scilly Islands venture has ruffled a few feathers.

‘We expect portfolio “realisations” over the coming months…’. ,as of finals end of June 2024.

AI related companies may attract higher bids than currently imagined.

Current market cap is well below NAV.

You may be right, there again I would not be surprised if a big pharma or a fund took the opportunity to grab a slice of such a promising investment. Time will tell.

Alternatively a major pharma might buy all of a share issue at significantly higher SP .

A positive update and outlook.

Queens university is awaiting news on a large amount of grant funding for work stream in conjunction with Fusion.

Correct.

Wiz sale for £19bn will raise the bar for GetVisibility.